Cargando…

Interleukins in the treatment of melanoma

Interleukins (ILs) and associated cytokines serve as the means of communication for immune cells and non-immune cells. The use of ILs in harnessing the immune system to cancer treatment has been a promising approach. ILs not only nurture an environment enabling cancer growth but also simultaneously...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Xinyuan, Dai, Wei, Li, Chunying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869617/ https://www.ncbi.nlm.nih.gov/pubmed/34985017 http://dx.doi.org/10.1097/CM9.0000000000001929

Ejemplares similares

Antitumor Activities of Interleukin-12 in Melanoma
por: Gao, Wei, et al.
Publicado: (2022)

Ubiquitination in melanoma pathogenesis and treatment
por: Ma, Jinyuan, et al.
Publicado: (2017)

Signal pathways of melanoma and targeted therapy
por: Guo, Weinan, et al.
Publicado: (2021)

Single-agent interleukin-2 in the treatment of metastatic melanoma
por: Petrella, T., et al.
Publicado: (2007)

Expression of interleukin 10 in human melanoma.
por: Krüger-Krasagakes, S., et al.
Publicado: (1994)

The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.
por: Hollingsworth, S. J., et al.
Publicado: (1996)

Interleukin 32 expression in human melanoma
por: Paz, Helicia, et al.
Publicado: (2019)

Interleukin-17 Inhibitors for the Treatment of Ankylosing Spondylitis
por: Huang, Jin-Xian, et al.
Publicado: (2020)

2349 The role of interleukin-23 in human melanoma
por: Jani, Aditi, et al.
Publicado: (2018)

Treatment of disseminated ocular melanoma with sequential fotemustine, interferon α, and interleukin 2
por: Becker, J C, et al.
Publicado: (2002)

Robust tumor immunity to melanoma mediated by interleukin 9
por: Purwar, Rahul, et al.
Publicado: (2012)

Reduced Interleukin-17-Expressing Cells in Cutaneous Melanoma
por: Tosi, Anna, et al.
Publicado: (2021)

Interleukin-8 in Melanoma Pathogenesis, Prognosis and Therapy—An Integrated View into Other Neoplasms and Chemokine Networks
por: Filimon, Anca, et al.
Publicado: (2021)

The Toxicity and Benefit of Various Dosing Strategies for Interleukin-2 in Metastatic Melanoma and Renal Cell Carcinoma
por: Pachella, Laura A., et al.
Publicado: (2015)

Metabolic rewiring directs melanoma immunology
por: Sun, Ningyue, et al.
Publicado: (2022)

Epigenetics Regulates Antitumor Immunity in Melanoma
por: Chen, Yuhan, et al.
Publicado: (2022)

Durability of Complete Response to Intralesional Interleukin-2 for In-Transit Melanoma
por: Khoury, Sami, et al.
Publicado: (2021)

Melanoma treatment in review
por: Domingues, Beatriz, et al.
Publicado: (2018)

Targeting of interleukin-17 in the treatment of psoriasis
por: Lønnberg, Ann Sophie, et al.
Publicado: (2014)

Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis
por: Koutruba, Nora, et al.
Publicado: (2010)

Interleukin 39: a new member of interleukin 12 family
por: LU, ZHIYU, et al.
Publicado: (2020)

SUN-LB27 Interleukin-8 - a Possible Target for Melanoma Treatment? In-Vitro Studies Based on Human Melanoma Cell Models
por: Ramaraj, Pandurangan
Publicado: (2020)

Oncolytic adenovirus expressing interleukin-18 improves antitumor activity of dacarbazine for malignant melanoma
por: Yang, Chunhua, et al.
Publicado: (2016)

Low-dose inhalation of interleukin-2 bio-chemotherapy for the treatment of pulmonary metastases in melanoma patients
por: Posch, C, et al.
Publicado: (2014)

Interleukin-7 and Interleukin-15 for Cancer
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

Inhibitory Effect of Melanoma Differentiation Associated Gene-7/Interleukin-24 on Invasion In Vitro of Human Melanoma Cancer Cells
por: Lin, Bi-wen, et al.
Publicado: (2013)

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
por: Lewis, Anne M, et al.
Publicado: (2006)

Adjuvant Treatment of Melanoma
por: Moreno Nogueira, J. A., et al.
Publicado: (2013)

Applications of nanotechnology for melanoma treatment, diagnosis, and theranostics
por: Chen, Jiezhong, et al.
Publicado: (2013)

Interleukin-33 modulates immune responses in cutaneous melanoma in a context-specific way
por: Peng, Liang, et al.
Publicado: (2021)

Advances in the Application of Nanomaterials to the Treatment of Melanoma
por: Wang, Zeqi, et al.
Publicado: (2022)

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma
por: Zoon, Christine Kathryn, et al.
Publicado: (2015)

CXCR7 promotes melanoma tumorigenesis via Src kinase signaling
por: Xu, Siran, et al.
Publicado: (2019)

Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells
por: Kreis, Stephanie, et al.
Publicado: (2007)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Interleukin-6 inhibitors in the treatment of rheumatoid arthritis
por: Hennigan, Stephanie, et al.
Publicado: (2008)

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis
por: Lytvyn, Yuliya, et al.
Publicado: (2023)

Rethinking Oncologic Treatment Strategies with Interleukin-2
por: Ko, Brian, et al.
Publicado: (2023)

Use of ipilimumab in the treatment of melanoma
por: Acharya, Utkarsh H, et al.
Publicado: (2013)

Bioelectric Applications for Treatment of Melanoma
por: Beebe, Stephen J., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_u31upkbmk839430ha1t76qtvfo